DPX COVID 19
Alternative Names: Covid-19 viral vaccine - IMV; DPX COVID-19; DPX COVID-19 vaccine - IMVLatest Information Update: 28 Apr 2024
At a glance
- Originator IMV
- Class COVID-19 vaccines; Peptide vaccines; Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Apr 2024 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in Canada
- 29 Dec 2020 Immunogenicity data from a preclinical study in COVID-2019 infections released by IMV
- 08 Oct 2020 DPX COVID 19 is available for licensing as of 08 Oct 2020. www.imv-inc.com